Home / Resources / Articles (page 70)

Articles

The list of articles below are ordered by most recent. You will find articles here that are also listed in other categories. The list below is a catch-all for all articles on the site.

Dulaglutide versus Insulin Glargine for Type 2 Diabetes

Does a once-weekly dulaglutide provide similar efficacy compared to basal insulin for patients with type 2 diabetes? In the pharmacological options available for type 2 diabetes, basal insulin such as insulin glargine is an effective method in control fasting blood sugar. However, the use of insulin is associated with hypoglycemia …

Read More »

Six Versus 4 Week Therapy for Osteomyelitis

According to research presented by Dr. Karim Gariani from the University of Zurich, three and six weeks of therapy give similar incidences of remission in diabetic foot osteomyelitis. Diabetic foot infections are either bone or soft tissue infections below the malleoli. It is the most common issue that can come …

Read More »

The association between serum DPP4 levels and cognitive decline in prenatal pregnant women with Gestational diabetes mellitus

Serum DPP4 levels may be associated with cognitive dysfunction in perinatal pregnant women with gestational diabetes mellitus  Gestational diabetes mellitus (GDM) occurs in about 7% of all pregnancies, ranging from 1% to 14%, depending on the specific population studied, and the diagnostic test used to assess the presence of gestational …

Read More »

Health Disparities among People with Diabetes in America and The Relationship of Race, Economic Status, and Ethnicity in Contributing to Health Inequality

Research results show that race, ethnicity, and socio-economic disparity influence the uptake of GLP-1 RA medication among people with diabetes which suggests that they are critical determinants of health. The issue of diabetes has been a topic for research over a long duration of time. Therefore, research is undertaken to …

Read More »

DPP-4 Inhibitors Vs. Sulphonylureas As Add-On to Metformin – Assessing CV Outcomes in Type 2 Diabetes

New retrospective study results compare the two most largely prescribed antidiabetic medication classes in addition to metformin, to determine the impact on the incidence of CV events in patients with T2DM. Dipeptidyl-peptidase-4 inhibitors (DPP-4i) and sulphonylureas (sulfonylureas in the US) (SU) are two of the most prescribed medication to date …

Read More »